Metagenomic Next-Generation Sequencing Identifies Enterovirus C and Elizabethkingia meningoseptica in Pediatric Central Nervous System Infections in Nepal

When a child develops a fever, a stiff neck, and confusion, doctors know they are facing a serious threat to the brain and its protective fluids. These symptoms point to infections of the central nervous system, such as meningitis or encephalitis. For decades, the standard way to find the culprit has been to look for specific suspects the doctor already expects to see. If a test is designed to find bacteria, it will miss a virus. If it looks for a known virus, it will overlook a rare fungus. This approach leaves a large number of patients without a clear answer, forcing doctors to treat them blindly or guess based on symptoms alone. In places like Nepal, where the landscape of disease is complex and changing, this gap in knowledge is particularly dangerous. A newer tool called metagenomic next-generation sequencing offers a different path. Instead of hunting for a single known suspect, this method reads the genetic code of everything present in a sample, allowing scientists to identify any virus, bacterium, or parasite without needing to know what they are looking for beforehand.

In a recent study conducted in eastern Nepal, researchers used this broad-spectrum genetic tool to investigate the causes of brain infections in children and adults. They collected fluid from the spinal column of two hundred patients who were suffering from suspected encephalitis, meningitis, or a combination of both. After extracting the genetic material from these fluids, they sequenced the DNA and RNA to see what microscopic life was hiding there. The results revealed two specific pathogens that had been missed by conventional testing: a bacterium called Elizabethkingia meningoseptica and a virus known as Enterovirus C. These findings were not just isolated cases; the study found that eight children carried the bacterium, nine children carried the virus, and four children were infected with both at the same time.

The researchers focused their analysis on samples taken from a tertiary hospital in Biratnagar between May and December 2023. While the study included patients of all ages, the positive results were concentrated almost entirely in infants and young children. The genetic analysis showed that the Elizabethkingia bacteria found in these patients were closely related to strains previously identified in healthcare settings, suggesting a link to hospital environments or medical care. The Enterovirus C, on the other hand, matched strains that have been seen in outbreaks across China, Pakistan, and India, specifically types known to cause eye infections but also capable of causing brain inflammation. The study noted that these viral strains were genetically similar to Coxsackievirus-A24, a type often associated with conjunctivitis, yet here they appeared in the spinal fluid of children with severe neurological symptoms.

One of the most striking aspects of the discovery was how difficult these infections were to spot using traditional methods. When doctors examined the spinal fluid under a microscope and tried to grow bacteria in a lab culture, the results were often negative or showed no growth. The fluid looked clear, and standard tests failed to identify the invaders. This silence from conventional diagnostics highlights a critical blind spot in medical care. The children infected with these pathogens presented with symptoms like fever, seizures, vomiting, and neck stiffness, yet the routine tests could not explain why they were sick. The study found that the chemical makeup of the spinal fluid in these cases did not follow the strict rules doctors usually rely on to distinguish between bacterial and viral infections. For instance, while bacterial infections often lower the sugar levels in the fluid, some of these children had normal sugar levels despite carrying a bacterium. Similarly, protein levels were elevated in ways that overlapped between the viral and bacterial groups, making it impossible to tell them apart based on chemistry alone.

The study also uncovered that four children were fighting off both the bacterium and the virus simultaneously. This co-infection adds another layer of complexity, as the presence of one pathogen might mask the other or alter how the body responds. The researchers traced the genetic fingerprints of the bacteria and viruses back to their origins. The Elizabethkingia strains matched those found in other medical contexts, while the Enterovirus strains were linked to populations in neighboring countries. This suggests that the diseases crossing the borders of Nepal are part of a larger regional pattern, yet they remain invisible to the current surveillance systems that rely on older testing methods.

Despite these clear findings, the authors caution that detecting genetic material does not always prove that a specific germ caused the illness, especially when the amount of genetic code found is small or when multiple organisms are present. They did not have the ability to confirm every positive result with a secondary test, which means the link between the germ and the disease remains a strong suggestion rather than a final proof for every single case. However, the consistency of the findings across multiple children, combined with the failure of standard tests to find anything, points to a real and significant presence of these pathogens. The study concludes that using this broad genetic sequencing method alongside standard clinical care could help doctors in Nepal and similar regions identify the true causes of brain infections. By revealing the hidden landscape of viruses and bacteria that routine tests miss, this approach offers a way to move beyond guessing and toward a more accurate understanding of what is making children sick.